PMID: 11916152Mar 28, 2002Paper

Modification of human erythrocyte pyruvate kinase by an active site-directed reagent: bromopyruvate

Journal of Enzyme Inhibition
N L Acan, N Ozer

Abstract

Human erythrocyte pyruvate kinase was modified with bromopyruvate and the kinetic behavior of the modified enzyme was investigated. When the enzyme was modified with bromopyruvate in the absence of adenosine-5'-diphosphate, phosphoenolpyruvate or fructose-1,6-diphosphate the inactivation followed a pseudo first-order kinetics. The inactivation rate constant, ks, was 1.84 +/- 0.15 min(-1). Kd of the bromopyruvate-enzyme complex was 0.14 +/- 0.03 mM. The presence of adenosine-5'-diphosphate, phosphoenolpyruvate or fructose-1,6-diphosphate in the modification medium or the presence of fructose-1,6-diphosphate in the assay medium resulted in deviation of the inactivation kinetics from pseudo first-order. Phosphoenolpyruvate was better than adenosine-5'-diphosphate for protection against bromopyruvate modification whereas fructose-1,6-diphosphate was ineffective. The modified enzyme showed negative cooperativity in the presence of fructose-1,6-diphosphate whereas in the absence of it no activity was detected.

References

Feb 1, 1979·Archives of Biochemistry and Biophysics·E Cardemil, J Eyzaguirre
Feb 21, 1977·Biochemical and Biophysical Research Communications·J A Badwey, E W Westhead
Jul 11, 1977·Biochemical and Biophysical Research Communications·J A Badwey, E W Westhead
Jan 1, 1988·Veterinary Research Communications·M N Mgasa, G K Mbassa
Mar 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·W N ValentineR A Brockway
Dec 1, 1973·Analytical Biochemistry·W Schaffner, C Weissmann
Dec 10, 1973·Biochemical and Biophysical Research Communications·G G Chang, R Y Hsu
Jul 1, 1972·Archives of Biochemistry and Biophysics·G H DeVries, S B Binkley
Feb 1, 1974·The Biochemical Journal·L G Dann, H G Britton
Oct 8, 1969·Biochemical and Biophysical Research Communications·T E Roche, B A McFadden
Nov 1, 1970·Archives of Biochemistry and Biophysics·J F Koster, W C Hulsmann
Dec 1, 1984·Biochemical Medicine·K Kilinç, N Ozer
Apr 1, 1984·Archives of Biochemistry and Biophysics·K Kilinç, N Ozer
Mar 1, 1983·British Journal of Haematology·W N Valentine, D E Paglia
Dec 1, 1958·Archives of Biochemistry and Biophysics·A TIETZ, S OCHOA
Jan 18, 1965·Biochemical and Biophysical Research Communications·H P MELOCHE

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.